Certain Common Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 27-MAR-2024.
March 26, 2024
Share
Certain Common Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 27-MAR-2024. These Common Stock will be under lockup for 183 days starting from 26-SEP-2023 to 27-MAR-2024.
Details:
The company executive officers, directors following this offering and other security holder(s) of five percent (5%) or more have agreed not to offer, sell, agree to sell, directly or indirectly, or otherwise dispose of any shares of common stock for a period of six months following the closing of this offering, subject to certain exceptions.
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
KNOW LABS, INC. 
